Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications
- PMID: 20055911
- PMCID: PMC2805836
- DOI: 10.1111/j.1365-2559.2009.03454.x
Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications
Abstract
Sebaceous neoplasia comprises a spectrum ranging from benign to malignant. Proper histological identification is important for treatment, prognosis and potential association with the Muir-Torre syndrome (MTS). Our increased understanding of the significance and pathogenesis of these tumours has led to improved risk stratification, screening recommendations, and treatment of patients with an initial presentation of a sebaceous tumour. This review focuses on the diagnostic and histological features of sebaceous lesions, the MTS, and recent insights into the molecular pathogenesis of sebaceous tumours.
Figures
References
-
- Li MaUC. Normal skin. In: Mills SE, editor. Histology for pathologists. Philadelphia: Lippincott, Williams and Wilkins; 2007.
-
- Danby FW. Why we have sebaceous glands. J Am Acad Dermatol. 2005;52:1071–1072. - PubMed
-
- Zouboulis CC, Baron JM, Bohm M, et al. Frontiers in sebaceous gland biology and pathology. Exp Dermatol. 2008;17:542–551. - PubMed
-
- Bayer-Garner IB, Givens V, Smoller B. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol. 1999;21:426–431. - PubMed
-
- Bieniek R, Lazar AJ, Photopoulos C, Lyle S. Sebaceous tumours contain a subpopulation of cells expressing the keratin 15 stem cell marker. Br J Dermatol. 2007;156:378–380. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
